STOCK TITAN

iRhythm Holdings signs $100M share buyback agreement

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

iRhythm Holdings, Inc. (IRTC) entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association, to repurchase an aggregate of $100.0 million of common stock under its previously announced program, which authorizes repurchases of up to $200.0 million. iRhythm will make an initial payment of $100.0 million and receive an initial share delivery representing approximately 80% of the total shares expected to be repurchased under the agreement.

The final share count will generally be based on average daily volume-weighted average prices on specified trading days during the agreement, less a discount and subject to adjustments. Final settlement is expected no later than the first quarter of 2027. At settlement, JPMorgan may deliver additional shares; in certain circumstances, iRhythm may have to make a cash payment or elect to deliver shares. The company expects to fund the transaction with existing cash and cash equivalents. JPMorgan may accelerate the agreement, which may also be terminated early in certain circumstances.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Accelerated share repurchase amount $100.0 million Aggregate common stock repurchase under the agreement
Share repurchase program authorization Up to $200.0 million Previously announced authorization for common stock repurchases
Initial share delivery Approximately 80% Of the total shares expected to be repurchased under the agreement
Expected final settlement No later than the first quarter of 2027 Accelerated share repurchase agreement
accelerated share repurchase agreement financial
"entered into an accelerated share repurchase agreement"
An accelerated share repurchase agreement is a deal where a company quickly buys back its own shares by paying a financial institution up front, while the institution delivers shares it borrows and settles the exact quantity later based on market prices. For investors this matters because it immediately reduces the number of shares outstanding and can boost per-share earnings, change cash and leverage levels, and signal management’s view on the stock’s value.
volume-weighted average prices financial
"average of the daily volume-weighted average prices"
Volume-weighted average price (VWAP) is the average trading price of a stock over a set period, where each trade’s price is weighted by how many shares were exchanged, so large trades influence the average more than small ones. Investors and traders use VWAP like a yardstick to judge whether a trade occurred at a good price relative to the market overall, similar to comparing the average price per pound when shopping where bigger purchases shift the average.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much stock is IRTC repurchasing under the agreement?

iRhythm agreed to repurchase an aggregate of $100.0 million of common stock through the accelerated share repurchase agreement, under its program authorizing repurchases of up to $200.0 million.

How will IRTC's final repurchase share count be determined?

The total number of shares will generally be based on the average of daily volume-weighted average prices on specified trading days during the agreement, less a discount and subject to adjustments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001388658false00013886582026-11-172026-11-17


  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 17, 2026
iRhythm Holdings, Inc.
(Exact name of Registrant as specified in its charter) 
Delaware001-3791841-3421287
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
699 8th Street, Suite 600
San Francisco, California 94103
(Address of principal executive office) (Zip Code)
(415) 632-5700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareIRTCThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 






Item 7.01. Regulation FD Disclosure.

On November 17, 2026, iRhythm Holdings, Inc., a Delaware corporation (the “Company”), issued a press release announcing its entry into the accelerated share repurchase agreement described under Item 8.01 below. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01, including Exhibit 99.1 to this Current Report on Form 8-K, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 8.01. Other Events.

On November 17, 2026, the Company entered into an accelerated share repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPMorgan”) to repurchase an aggregate of $100.0 million of the Company’s common stock, par value $0.001 per share (“Common Stock” and such transaction, the “ASR Transaction”). The ASR Transaction is being made under the Company’s previously announced share repurchase program, pursuant to which the Company’s board of directors authorized the repurchase of up to $200.0 million of Common Stock, as disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2026.

Under the terms of the ASR Agreement, the Company will make an initial payment of $100.0 million to JPMorgan and will receive an initial delivery of shares of Common Stock representing approximately 80% of the total number of shares of Common Stock expected to be repurchased under the ASR Agreement.

The total number of shares of Common Stock that the Company will repurchase under the ASR Agreement will generally be based on the average of the daily volume-weighted average prices of Common Stock on specified trading days during the term of the ASR Agreement, less a discount and subject to adjustments, pursuant to the terms and conditions of the ASR Agreement. At settlement, JPMorgan may be required to deliver additional shares of Common Stock to the Company, or, in certain circumstances, the Company may be required to make a cash payment or, at its election, deliver shares of Common Stock to JPMorgan. Final settlement of the ASR Transaction is expected to occur no later than the first quarter of 2027, and may be accelerated at the option of JPMorgan or terminated early in certain circumstances. The ASR Agreement contains customary terms for transactions of this type, including additional provisions for adjustments, the circumstances under which the ASR Agreement may be accelerated, extended or terminated early, and representations and warranties of the parties.

The Company expects to fund the ASR Transaction with existing cash and cash equivalents.

JPMorgan and its affiliates have provided, and may in the future provide, investment banking, commercial banking and other financial services to the Company and its affiliates, for which they have received, and may in the future receive, customary fees and expenses, including serving as administrative agent, a lender, a joint lead arranger and a joint bookrunner under the Company’s credit agreement.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the ASR Transaction, including the total number of shares of Common Stock to be repurchased under the ASR Agreement, the timing of final settlement of the ASR Transaction, and statements regarding the Company’s share repurchase program. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual events or results to differ materially from those expressed or implied by the forward-looking statements, including, but not limited to, risks that the ASR Transaction may not be completed in the timeframe or in the manner the Company expects, or at all, risks relating to the final number of shares of Common Stock repurchased under the ASR Agreement, which will depend on the trading price of the Common Stock during the term of the ASR Agreement, risks that, in certain circumstances, the Company may be required to make a cash payment or deliver shares of Common Stock to JPMorgan upon settlement of the ASR Transaction, risks that other repurchases of Common Stock under the share repurchase program may not be conducted in the timeframe or in the manner the Company expects, or at all, and the important factors discussed under the caption “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 5, 2026, and the Company’s other filings with the SEC. These factors could cause actual results to differ



materially from those indicated by the forward-looking statements made in this Current Report on Form 8-K. Any such forward-looking statements represent management’s estimates as of the date of this Current Report on Form 8-K. While the Company may elect to update such forward-looking statements at some point in the future, the Company disclaims any obligation to do so, even if subsequent events cause its views to change.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits.


Exhibit
No.
Description
99.1
Press release issued by iRhythm Holdings, Inc., dated November 17, 2026.
104Cover Page Interactive Data File (formatted as Inline XBRL)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IRHYTHM HOLDINGS, INC.
Date: November 17, 2026
By:/s/ Daniel Wilson
Daniel Wilson
Chief Financial Officer



 


 

Filing Exhibits & Attachments

4 documents

Keep reading